Clinical Trial Update: Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency [Phase 4]

View source ↗

Summary

Phase 4 randomized trial evaluating erythropoiesis-stimulating agents with ferric carboxymaltose in cancer patients with functional iron deficiency-associated a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoid Neoplasm
• Solid Tumor

Drugs mentioned

• Erythropoiesis-stimulating agents (ESA) (erythropoiesis-stimulating agent)
• Ferinject (ferric carboxymaltose)

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Solid Cancer Metastatic Disease, Lymphoid Disease | Phase 4 | Status: TERMINATED